Extraordinary General Meeting of Meda Aktiebolag (publ) At

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

Aug 2, 2016 at 11:15 AM

Extraordinary General Meeting of Meda Aktiebolag (publ)

At the request of Mylan N.V., which after completion of its public offer to the shareholders of Meda Aktiebolag (“Meda” or the “Company”) owns more than nine -tenths of the shares in Meda, the shareholders of Meda are hereby invited to attend the Extraordinary General Meeting on Thursday August 25, 2016 at 3 p.m. on Meda’s premises at Pipers väg 2A, Solna, Sweden. Right to participate Shareholders who wish to participate shall: both be registered in the share register held by Euroclear Sweden AB on Friday August 19 2016, and and send notice of their intention to participate to Meda by Friday, August 19 2016. In order to be entitled to vote at the Extraordinary General Meeting, shareholders whose shares are registered in the names of nominees must temporarily register their shares in their own names with Euroclear Sweden AB by Friday, August 19, 2016. Consequently, shareholders should notify nominees well in advance of that date. Notification of attendance Notice of Extraordinary General Meeting participation shall be given via mail to Meda AB, EGM, Box 7835, SE-103 98 Stockholm, Sweden, via phone at +46-8-402 90 49, or on the company’s website www.meda.se. In the notice the shareholder’s name, Swedish civil registration number or corp.reg.no, address, number of shares, phone number (daytime), and information about accompanying assistants (no more than two) shall be stated. If participating by proxy, please submit the original proxy document to Meda before the Extraordinary General Meeting. The expiry date of the proxy document may be no more than five years from its issuance. If the proxy is issued by a legal entity, a certified copy of the registration certificate for the legal entity must also be submitted. The proxy form is available at www.meda.se, and will be sent to shareholders who request the form and specify an address. Proposal for agenda At the Extraordinary General Meeting, the following matters will be dealt with. 1. Opening of the EGM 2. Election of the EGM chairman 3. Establishment and approval of the voting list 4. Approval of the agenda 5. Election of one or two persons to verify the minutes 6. Determination of whether the EGM was duly convened 7. Determination of the number of board members and deputy board members to be appointed 8. Determination of board remuneration 9. Election of board members and chairman of the board 10. Closing of the EGM Proposed resolutions Item 7-9: proposed board members and remuneration The Company has been informed that Mylan N.V., holding more than 90 percent of the shares and votes in the company as at the date of this notice, proposes the following: that the board shall consist of three ordinary board members and no alternate members; that no remuneration shall be paid to the board members for the board assignments; that the following Mylan group executives are elected as new board members, - Caroline Dixon, born 1968; Head of Finance, Northern Europe - Jacek Glinka, born 1963; President, Europe - Colleen Ostrowski, born 1973; Treasurer; and that Jacek Glinka is elected as chairman of the board. Further information At the time of publication of this notice, the number of shares and votes in Meda total 365,467,371. Only class A shares have been issued. The company holds no own shares. On the request of a shareholder the board of directors and the CEO shall provide information at the EGM concerning conditions that could influence the assessment of an item on the agenda, provided that the board deems that disclosure is possible without causing material damage to the company. Solna, Sweden, August 2016 The board of directors Meda AB (publ) For further inquiries, please contact: Paula Treutiger, VP Corporate Communications & Sustainability ph: +46 733 -666 599 paula.treutiger@meda.se This press release was submitted for publication 17:00 p.m. CET on 2 August 2016. MEDA AB (publ) is a leading international specialty pharma company. Meda’s products are sold in more than 150 countries worldwide and the company is represented by its own organizations in over 60 countries. The Meda share is listed under Large Cap on Nasdaq Stockholm. Find out more, visit www.meda.se.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

JiMMYBAR! Expands Creatine Market with Target Launch

JiMMYBAR! Breaks New Ground in Supplements You ever notice how some companies just know how to shake things up? Take JiMMYBAR!, for instance. The moment I read they’re making moves to get their Creatine + Protein bars into Target stores nationwide, starting October 4, I thought, “That’s one way to drag creatine out from the dusty tub and onto the shelves of...

Purina Institute Highlights Nutritional Science at WSAVA 2026

A Global Stage for Pet Nutrition Science The folks over at the Purina Institute are back in the spotlight as they gear up to throw their weight behind the 51st World Small Animal Veterinary Association (WSAVA) Congress in Warsaw, Poland. Set for October 13-15, 2026, this isn’t just another event—they're bringing some serious clout with their 'Food for Thought'...

Epic Political Thriller Explores Humanity's Future

Adams' Provocative Debut Asks Timeless Questions Sometimes life throws a philosophical curveball, and that's exactly what John C. Adams has done with his debut novel, The Third Phase. This isn't your average political yarn—it's an intricate tapestry intertwining political intrigue, deep spiritual inquiry, and hearty doses of classic philosophy. A Whirlwind Journey...

ROKFORM’s Signal Card: A Wallet Tracker for All

The Gadget You Didn't Know You Needed Ever feel that momentary panic when your wallet seems to have vanished into thin air? ROKFORM's fresh offering, the Signal Card, tackles that heart-stopping moment head-on. They've taken the mundane act of misplacing your wallet and transformed it with their sleek, credit-card-sized tracker. This baby pairs seamlessly with Apple Find...

Community Banks Missing $106B Lending Opportunity?

A Missed Opportunity for Community Banks It's a classic tale: community banks sleepwalking while big players snatch up low-hanging fruit right in their own backyards. According to the latest report by Cornerstone Advisors, commissioned by Teslar Software, these banks are essentially leaving $106 billion on the table when it comes to consumer lending. That's not just chump...

Northern Jet Names Veteran Matthew Harris as CEO

Fresh Leadership at Northern Jet Well, if you didn’t see this coming, you’ve been snoozing on the tarmac. Northern Jet, no stranger to the skies after three decades, just roped in Matthew Harris as their new CEO from October 2, 2026. They're pulling in this hotshot with more than 25 years riding the turbulence of private aviation. And listen to this: his marching...

Charter Next Generation Unveils Gen 2 MDO-PE Films

Peering Into CNG's Latest Innovation Charter Next Generation (CNG) just threw down a hefty gauntlet with its launch of next-gen machine-direction-oriented polyethylene (MDO-PE) solutions. They're pushing the envelope on what recycle-ready packaging can do, folks. Let's not mince words—other players in the field better have their game faces on. This ain't just another...

Pushing for National Liver Cancer Awareness in 2026

The Urgency of Liver Cancer Awareness Death doesn’t wait, does it? When liver cancer is the villain in question, every moment becomes precious because this beast doesn’t roar until it’s too late. Here we are in 2026, staring at nearly 31,000 annual deaths in the U.S. alone. But hope flickers with a new congressional resolution aiming to slap a bright spotlight on...

Truss Financial Tackles Home Equity Closing Delays

Truss Financial Group's Bold Move Against Closing Delays In real estate, time is money. Even the most casual market observer could tell you delays can slice through a deal like a hot knife through butter. That's the headache home equity borrowers face, blindsided by closing delays that sneak up on them without warning. An Industry Bottleneck Finally Addressed Enter Truss...

Cure Blindness Project's 770K Screenings for World Sight Day

Visionary Steps Toward a Brighter Future No two words could describe the task that Cure Blindness Project is tackling this year: vision and action. Marking World Sight Day on October 8, they plan to usher in 770,000 eye screenings across Asia, Africa, and the Caribbean. These initiatives aren't just numbers—they're a colossal step toward lifting the veil of avoidable...